Triple Analysis: Angiogenesis, Cancer Vaccines and Antibodies

BioSeeker Group AB
March 19, 2013
5072 Pages - SKU: BIOS5014693
Vaccine Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) - Forecasts to 2019
1/26/2015 | published by: MarketsandMarkets
Vaccine Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) - Forecasts to 2019 The vaccines market is  |  read more...
USD 4,650
Cancer Vaccines: Technologies and Global Markets
1/1/2015 | published by: BCC Research
Cancer Vaccines: Technologies and Global Markets REPORT HIGHLIGHTS The global market for cancer vaccines was about $4.5 billion in 2013. This market reached about $4.0 billion in 2014 and is expected to reach  |  read more...
USD 6,650
Global Markets for Research Antibodies
1/1/2015 | published by: BCC Research
Global Markets for Research Antibodies The global market for research antibodies reached $2 billion in 2013 and nearly $2.2 billion in 2014. This market is expected to reach nearly $3 billion in 2019, registering  |  read more...
USD 6,650
Impact of Biosensing Technologies (Technical Insights)
12/26/2014 | published by: Frost & Sullivan
Impact of Biosensing Technologies (Technical Insights) Research Scope Biosensors are devices which sense biological signals/analyte and then use a transducer to change it to a corresponding electrical energy. Biosensors are differentiated based  |  read more...
USD 6,500
Advances in Biosensing Technologies (Technical Insights)
12/26/2014 | published by: Frost & Sullivan
Advances in Biosensing Technologies (Technical Insights) Scope of Research The Research Service is focused primarily on the technical advances occurring in the biosensor industry with respect to human population. The advances where  |  read more...
USD 6,500
Antibodies in Oncology: Drug Pathway Analyzer 2015
1/12/2015 | published by: BioSeeker Group AB
Extra value: One year of free online updates included with this product There are today at least 701 antibody drugs known to affect more than 213 specific intracellular signaling pathways for the treatment of more than  |  read more...
USD 6,746
Antibodies in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the second wave in the lucrative field  |  read more...
USD 6,746
Enzyme-Linked Immunosorbent Assay (ELISA)
1/1/2015 | published by: Global Industry Analysts
Enzyme-Linked Immunosorbent Assay (ELISA) This report analyzes the worldwide markets for Enzyme-Linked Immunosorbent Assay (ELISA) in US$ Thousands by the following Product Segments: ELISA Development Sets and Antibody Pairs, and ELISA Kits. The report provides  |  read more...
USD 4,950
Intravenous Immunoglobulin (IVIg)
1/1/2015 | published by: Global Industry Analysts
Intravenous Immunoglobulin (IVIg) This report analyzes the worldwide markets for Intravenous Immunoglobulin (IVIg) in US$ Million and in Kilograms. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest  |  read more...
USD 4,950
Antibody Drugs: Technologies and Global Markets
1/1/2015 | published by: BCC Research
Antibody Drugs: Technologies and Global Markets The global market for antibody drugs was worth nearly $63.4 billion in 2013. This market is expected to grow at a compound annual growth rate (CAGR) of 12.2%  |  read more...
USD 6,650
 

SELECT A LICENSE

    PDF E-mail From Publisher  USD 5,175  
    Global Site License Fulfilled by Publisher  USD 12,937.50  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!